Marc Zapatka

31PUBLICATIONS
234CO-AUTHORS
Molecular targetsPredictive and prognostic markersHaematological tumoursEpigenetics (incl. genome methylation and epigenomics)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (31)

|Oct 28, 2026
Neuroendocrine Differentiation Mediates Escape from HER2-Targeted Therapy in Breast Cancer.

|Sep 24, 2026
Divergent medulloblastoma chromatin states disclose KDM2B as a selective dependency.

|Sep 15, 2026
High-dimensional spectral flow cytometry uncovers progressive T-cell exhaustion and myeloid cell reprogramming in a CLL mouse model.

|Oct 31, 2025
Delivering precision oncology in metastatic breast cancer: Clinical impact of comprehensive genomic profiling-The CATCH experience.

Mario Hlevnjak, Sabine Heublein, Verena Thewes

|Oct 21, 2025
Pipeline Olympics: continuable benchmarking of computational workflows for DNA methylation sequencing data against an experimental gold standard.

Yu-Yu Lin, Kersten Breuer, Dieter Weichenhan

|Aug 07, 2025
Integrative multi-omics reveals a regulatory and exhausted T-cell landscape in CLL and identifies galectin-9 as an immunotherapy target.

L Llaó-Cid, Jkl Wong, I Fernandez Botana

Pageof 6

Frequent Collaborators

10 joint publications

Peter Lichter

6 joint publications

Martina Seiffert

5 joint publications

Sascha Dietrich

5 joint publications

Matthias Schlesner